AZIYO BIOLOGICS INC-CLASS A (AZYO)

US05479K1060 - Common Stock

1.49  +0.03 (+2.05%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

AZIYO BIOLOGICS INC-CLASS A

NASDAQ:AZYO (9/6/2023, 7:00:01 PM)

1.49

+0.03 (+2.05%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap24.21M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AZYO Daily chart

Company Profile

Aziyo Biologics, Inc. operates as a biotechnology company. The company is headquartered in Silver Spring, Maryland and currently employs 151 full-time employees. The company went IPO on 2020-10-08. The firm has developed a portfolio of regenerative products using both human and porcine tissue that are designed to be as close to natural biological material. The firm operates in four segments: Device Protection, Women's Health, Orthobiologics, and Cardiovascular. Its product portfolio includes CanGaroo, SimpliDerm, ViBone, OsteGro V, Fiber VBM, ProxiCor, Tyke, and VasCure. These products are primarily sold to healthcare providers or commercial partners. In device protection, it sells biological envelopes that form a natural, systemically vascularized pocket for holding implanted electronic devices. In cardiovascular, the Company sells its specialized porcine small intestine submucosa (SIS ECM) for use as an intracardiac and vascular patch. The company also sells human tissue products under contract manufacturing and other arrangements with corporate customers.

Company Info

AZIYO BIOLOGICS INC-CLASS A

12510 Prosperity Drive, Suite 370

Silver Spring MARYLAND 20904

P: 12402471143.0

CEO: Ronald Lloyd

Employees: 151

Website: https://www.aziyo.com/

AZYO News

News Image8 months ago - Elutia Inc.Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference

SILVER SPRING, Md., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today...

News Image8 months ago - Aziyo BiologicsAziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures

Case provides first histologic evidence that CanGaroo can catalyze development of new healthy tissue layer within an existing cardiac implantable...

News Image9 months ago - Aziyo BiologicsAziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company

Negotiating multiple LOIs to divest Orthopedic business CanGaroo® RM 510(k) resubmission to the FDA remains on track SimpliDerm® quarterly net sales up...

News Image9 months ago - Aziyo BiologicsAziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

SILVER SPRING, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a company that develops and commercializes biologic...

News Image9 months ago - SWK Holdings CorporationSWK Holdings Highlights Recent Achievements and Provides Portfolio Update

/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and...

News Image10 months ago - Seeking AlphaAziyo Biologics recalling bone repair products (NASDAQ:AZYO)

Aziyo Biologics (AZYO) is recalling its viable bone matrix products after two patients developed an infection. Read more here.

AZYO Twits

Here you can normally see the latest stock twits on AZYO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example